Drug application
REDITREX (METHOTREXATE)
Drugs@FDA NDA 210737 · NORDIC GRP
Key facts
| Drug name | REDITREX |
|---|---|
| Active ingredients | METHOTREXATE |
| Application type | NDA |
| Application number | 210737 |
| Company | NORDIC GRP |
| Dosage forms | SOLUTION, SUBCUTANEOUS |
| Strength | 7.5MG/0.3ML (7.5MG/0.3ML) |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Efficacy |
| Latest submission status date | Nov 27, 2019 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: